WaveMan
WaveMan · Company
GEVO · Gevo, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

GEVO Gevo (GEVO) Insider Trading, Ownership & Congress Trades

Materials · Industrial organic chemicals · CIK 0001392380
C-suite buying · 1Form 144 · 10
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
71
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $62.9K priced

What the filings say about GEVO

Insiders, 180 days
-$1.6M net sold
2 buyers · 7 sellers · 14% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$552.3K
10 notices

Gevo insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Gevo, Inc. insiders sold a net $1.6M of stock across 143 Form 4 purchases and sales, with 2 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
SELL
2026-09-04 SECtraded 2026-09-03
3,333
$5.7K
-30.9%
Context
  • 14 earlier Form 4 trades (code P or S) here by this insider (14 sales), the last on Aug 6, 2026.
  • The trade is 0.1% of the 3,320,455 shares held after it.
  • 3 other insiders sold within 30 days.
  • 71 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Gruber Patrick R. sold about $5.7K of GEVO under a 10b5-1 plan on Sep 3, 2026; 3 other insiders sold within 30 days and 71 funds added in the latest 13F quarter.
Chief of Staff
SELL
2026-09-04 SECtraded 2026-09-03
1,221
$2.1K
-30.9%
Context
  • 15 earlier Form 4 trades (code P or S) here by this insider (15 sales), the last on Aug 6, 2026.
  • The trade is 0.2% of the 684,817 shares held after it.
  • 3 other insiders sold within 30 days.
  • 71 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief of Staff Bowron Kimberly T sold about $2.1K of GEVO under a 10b5-1 plan on Sep 3, 2026; 3 other insiders sold within 30 days and 71 funds added in the latest 13F quarter.
SELL
2026-09-04 SECtraded 2026-09-03
1,514
$2.6K
-30.9%
Context
  • 16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Aug 6, 2026.
  • The trade is 0.1% of the 1,500,789 shares held after it.
  • 3 other insiders sold within 30 days.
  • 71 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO Bloom Paul D sold about $2.6K of GEVO under a 10b5-1 plan on Sep 3, 2026; 3 other insiders sold within 30 days and 71 funds added in the latest 13F quarter.
BUY
2026-08-24 SECtraded 2026-08-21
50,000
$77.0K
-32.5%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 41.7% of the 120,000 shares held after it.
  • 1 other insider bought within 30 days.
  • 71 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Barber James J bought about $77.0K of GEVO on Aug 21, 2026, the largest insider purchase at the company since 2022; 1 other insider bought within 30 days and 71 funds added in the latest 13F quarter.
Chief Legal & Emrg Biz Officer
BUY
2026-08-24 SECtraded 2026-08-21
12,500
$19.4K
-32.5%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 4.5% of the 276,788 shares held after it.
  • 1 other insider bought within 30 days.
  • 71 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal & Emrg Biz Officer Kettner David Michael bought about $19.4K of GEVO on Aug 21, 2026, the largest insider purchase at the company since 2022; 1 other insider bought within 30 days and 71 funds added in the latest 13F quarter.
143 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Showing the latest few. to see 138 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$1.6M over 180 days
-$379.8K over 90 days
below 72% of Materials
Congress
no House purchase disclosed in the last 12 months
Funds
71 funds bought in last quarter
below 68% of Materials
Revenue
+849.3% year over year
more than 99% of Materials
Margin
-21.1% net margin
below 79% of Materials
Buybacks
$596.0K repurchased, FY to 2026-06-30
the lowest in Materials
Short interest
9.7% of the float short (float per yahoo 2026-10-26) · 5.9 days to cover · settled 2026-09-30
more than 83% of Materials
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch GEVO

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-52.7%12M
-54%-31%-8%+15%2025-102025-122026-022026-042026-062026-082026-10 2026-08-06 · Gruber Patrick R. sold $373.8K2026-05-27 · Gruber Patrick R. sold $328.2K2026-03-30 · Ryan Christopher Michael sold $276.0K2026-03-12 · Mize Gary W. sold $250.6K2026-06-12 · Gruber Patrick R. sold $220.6K2025-12-05 · Agiri Oluwagbemileke Yusuf sold $169.3K2026-05-27 · Ryan Christopher Michael sold $154.4K2025-11-13 · Battershell Carol Jane sold $152.7K2026-05-27 · Bloom Paul D sold $133.3K2026-06-12 · Agiri Oluwagbemileke Yusuf sold $88.2K2026-03-31 · Ryan Christopher Michael sold $88.2K2026-08-21 · Barber James J bought $77.0K2025-11-03 · Shafer Andrew sold $67.9K2026-05-27 · Shafer Andrew sold $57.5K2026-05-27 · Agiri Oluwagbemileke Yusuf sold $56.6K2026-06-12 · Ryan Christopher Michael sold $50.3K2026-06-12 · Bloom Paul D sold $50.3K2026-03-12 · Fitzgerald Lindsay Clinton sold $50.2K2026-08-06 · Bloom Paul D sold $48.1K2026-05-27 · Bowron Kimberly T sold $44.2K2026-08-06 · Agiri Oluwagbemileke Yusuf sold $28.0K2026-06-12 · Bowron Kimberly T sold $22.1K2026-08-21 · Kettner David Michael bought $19.4K2026-08-06 · Bowron Kimberly T sold $15.9K2026-04-01 · Shafer Andrew sold $15.0K2026-06-12 · Shafer Andrew sold $13.5K2026-03-10 · Shafer Andrew sold $12.3K2026-05-01 · Shafer Andrew sold $11.1K2025-12-22 · Shafer Andrew sold $10.9K2025-11-20 · Shafer Andrew sold $9.9K2026-01-20 · Shafer Andrew sold $9.9K2026-06-12 · Gendenjamts Davaajargal sold $6.1K2025-12-04 · Gendenjamts Davaajargal sold $5.9K2026-09-03 · Gruber Patrick R. sold $5.7K2026-09-03 · Bloom Paul D sold $2.6K2026-09-03 · Bowron Kimberly T sold $2.1K2026-09-03 · Bloom Paul D filed to sell $2.6K2026-09-03 · Bowron Kimberly T filed to sell $2.1K2026-09-03 · Gruber Patrick R. filed to sell $5.7K2026-09-03 · Ryan Christopher Michael filed to sell $2.6K2026-08-06 · Agiri Oluwagbemileke Yusuf filed to sell $28.0K2026-08-06 · Bloom Paul D filed to sell $48.1K2026-08-06 · Bowron Kimberly T filed to sell $15.9K2026-08-06 · Fitzgerald Lindsay Clinton filed to sell $11.9K2026-08-06 · Ryan Christopher Michael filed to sell $61.8K2026-08-06 · Gruber Patrick R. filed to sell $373.8K
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns GEVO: institutional holders (13F)

13F holdings, latest reported quarter
18,328,928 sh
$27.5M
13,430,525 sh
$20.1M
5,576,328 sh
$8.4M

Congress trades in GEVO

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

GEVO planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Bloom Paul D
Filed 2026-09-03
$2.6K
Bowron Kimberly T
Filed 2026-09-03
$2.1K
Gruber Patrick R.
Filed 2026-09-03
$5.7K
Ryan Christopher Michael
Filed 2026-09-03
$2.6K
Agiri Oluwagbemileke Yusuf
Filed 2026-08-06
$28.0K

GEVO mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
M3Sixty Income and Opportunity Fund
$651.0K position · as of 2026-05-31
3.9%
Invesco WilderHill Clean Energy ETF
$7.9M position · as of 2026-07-31
1.9%
ALPS Clean Energy ETF
$689.6K position · as of 2026-05-31
0.5%
State Street(R) SPDR(R) S&P(R) Oil & Gas Exploration & Production ETF
$12.6M position · as of 2026-06-30
0.4%
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares
$624.3K position · as of 2026-07-31
0.3%
GMO Climate Change Fund
$1.2M position · as of 2026-05-31
0.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $1.6M sold by insiders over 180 days, 71 funds added last quarter, $552.3K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Same sector, ranked by filing activity
Sector by SEC SIC code

GEVO financials

Revenue growth
+849.3%
XBRL, annual
Net margin
-21.1%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$177.5M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-119.9%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
-$56.7M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.61x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Cash flow to debt
-0.10x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Return on equity
-57.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-35.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on capital employed
-33.2%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$390.9M
market value at close 2026-10-26 on 2026-08-05 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
FCF yield
-20.1%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$160.6M$16.9M$17.2M$1.2M
Operating income-$20.2M-$90.8M-$81.8M-$102.7M
Net income-$33.8M-$78.6M-$66.2M-$98.0M
EPS (diluted)-0.14-0.34-0.28-0.44
Operating cash flow-$13.4M-$57.4M-$53.7M-$44.3M
Cash$81.2M$189.4M$298.3M$237.1M
Long-term debt$164.8M$67.1M$21.0K$67.4M
Buybacksn/a$4.7Mn/an/a
SEC XBRL, fiscal years, as known on 2026-10-28

GEVO Stock Sonar score 6/7 axes

Find similar shapesCompare

GEVO ranks highest on growth (99th percentile) and risk and compliance (68th), and lowest on profitability (10th), among Materials peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
10
Inputs
  • Return on equity-57.0% · 11 pct, sector of 100
  • Return on assets-35.2% · 13 pct, sector of 120
  • Return on invested capitaltax provision or pre-tax income not filed for the four quarters
  • Return on capital employed-33.2% · 6 pct, sector of 96
Financial health
38
Inputs
  • Debt to equity0.61x · 55 pct, sector of 104
  • Cash flow to debt-0.10x · 21 pct, sector of 103
Growth
99
Inputs
  • Revenue growth, YoY+849.3% · 99 pct, sector of 128
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
55
Inputs
  • Net Form 4 buying (codes P and S), 180d-$1.6M · 28 pct, sector of 80
  • Insider buyers, 180d2 · 82 pct, sector of 80
Institutional and government
53
Inputs
  • Funds adding, latest quarter71 · 32 pct, sector of 118
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quarters$1.1M · 74 pct, sector of 40
Risk and compliance
68
Inputs
  • Short interest, % of float+9.7% · 20 pct, sector of 143
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 103
  • New text in Risk Factors, latest 10-K+4.7% · 85 pct, sector of 111
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

GEVO filings, in plain words

Are Gevo insiders buying or selling GEVO?

In the 180 days to 2026-10-28, Gevo insiders were net sellers, a net $1.6M: $96.4K of purchases and $1.7M of sales reported on Form 4, by 2 buyers and 7 sellers.

Are there planned insider sales of GEVO?

Yes. 10 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $552.3K of stock; the latest, by Bloom Paul D, was filed 2026-09-03.

Read the full summary

In the 180 days to 2026-10-28, Gevo insiders were net sellers of GEVO, a net $1.6M across purchases and sales reported on Form 4 by 2 buyers and 7 sellers. Sales outweighed purchases more than tenfold by value. 2 different insiders reported purchases within the last 90 days, a cluster buy, which is rarer than a single purchase. 14% of the 21 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 10 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $552.3K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing